3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
6
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Multiple Myeloma
1
Meningioma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Hypogonadism
1
Head and Neck Neoplasms
1
Cognitive/Functional Effects
1
Cognitive Dysfunction
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Lenalidomide
8
Dexamethasone
7
Bortezomib
6
Cyclophosphamide
5
fludarabine
3
carfilzomib
3
belantamab mafodotin
3
pomalidomide
2
fludarabine phosphate
2
daratumumab
2
Melphalan
2
Etoposide
2
Calcium Dobesilate
2
poly ICLC
1
pembrolizumab
1
isatuximab
1
elotuzumab
1
citarinostat
1
Whole-Body Irradiation
1
Thalidomide
1
Tacrolimus
1
Sirolimus
1
Resistance Training
1
Radiotherapy
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
PVX-410 vaccine
1
Mycophenolic Acid
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
Mental Status and Dementia Tests
×
90 days
×
Clear all
No trials found.